Dopamine D1, D2, D3 Receptors, Vesicular Monoamine Transporter Type-2 (VMAT2) and Dopamine Transporter (DAT) Densities in Aged Human Brain

Higher Binding of the Dopamine D3 Receptor-Preferring Ligand [11C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study

(2012) I. Boileau et al.   JOURNAL OF NEUROSCIENCE

No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson Disease

(2012) LinLin Tian et al.   PLoS One

Characterization of extrastriatal D2 in vivo specific binding of [18F](N-methyl)benperidol using PET

(2012) Sarah A. Eisenstein et al.   SYNAPSE

Modulation of Striatal Projection Systems by Dopamine

(2011) Charles R. Gerfen et al.   Annual Review of Neuroscience

Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatum

(2011) Miranda M. Lim et al.   NEUROREPORT

Striatal and Extrastriatal Dopamine D2/D3 Receptors in Schizophrenia Evaluated With [18F]fallypride Positron Emission Tomography

(2010) Lawrence S. Kegeles et al.   BIOLOGICAL PSYCHIATRY

Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist

(2010) Graham Searle et al.   BIOLOGICAL PSYCHIATRY

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy

(2010) Andri C. Tziortzi et al.   NEUROIMAGE

Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study

(2010) A. Jucaite et al.   NEUROSCIENCE

[3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: A selective radioligand for dopamine D3receptors. II. Quantitative analysis of dopamine D3and D2receptor density ratio in the caudate-putamen

(2010) Jinbin Xu et al.   SYNAPSE

Dopamine D2 Receptor Levels in Striatum, Thalamus, Substantia Nigra, Limbic Regions, and Cortex in Schizophrenic Subjects

(2009) Robert M. Kessler et al.   BIOLOGICAL PSYCHIATRY

Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function

(2009) Chiara Fiorentini et al.   CURRENT OPINION IN PHARMACOLOGY

Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925

(2009) Ariel Graff-Guerrero et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia

(2009) M. Carbon et al.   NEUROLOGY

[3H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D3receptors. I. In vitro characterization

(2009) Jinbin Xu et al.   SYNAPSE

In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice

(2009) Eugenii A. Rabiner et al.   SYNAPSE

Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function

(2009) André R. Troiano et al.   SYNAPSE

New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems

(2008) Fabrizio Micheli et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Identification of Dopamine D1–D3Receptor Heteromers

(2008) Daniel Marcellino et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Strain differences in the expression of dopamine D1 receptors in Wistar–Kyoto (WKY) and Wistar rats

(2008) Andrew Novick et al.   LIFE SCIENCES

Reciprocal Regulation of Dopamine D1 and D3 Receptor Function and Trafficking by Heterodimerization

(2008) C. Fiorentini et al.   MOLECULAR PHARMACOLOGY